Successful targeted therapy of advanced lung cancer

F. Gamarra (Munich, Germany)

Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Disease area: Thoracic oncology

Slide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Gamarra (Munich, Germany). Successful targeted therapy of advanced lung cancer. Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Michele Gallo - 12.10.2013 09:08
Important contribution
You must Login to comment this presentation.


Related content which might interest you:
Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015


Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Effectiveness of chemotherapy for advanced lung cancer in the elderly
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer
Source: Eur Respir J 2014; 43: 240-249
Year: 2004



A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012

Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001

Mianserin therapy in advanced lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Use of 2nd-line polychemotherapy in advanced nonsmall cell lung cancer – a reasonable approach
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003

Prevalence and effectiveness of third-line therapy for advanced non-small cell lung cancer (A-NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Nonsurgical treatment of recurrent lung cancer
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007


Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019